Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2019

Calvarial Langerhans cell histiocytosis in an Adult: Typical
imaging findings in an atypical age group
Amjad Samara
Washington University School of Medicine in St. Louis

Jordan Nepute
Washington University School of Medicine in St. Louis

Hsiang-Chih Lu
Washington University School of Medicine in St. Louis

Richard J. Perrin
Washington University School of Medicine in St. Louis

Rami W. Eldaya
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Samara, Amjad; Nepute, Jordan; Lu, Hsiang-Chih; Perrin, Richard J.; and Eldaya, Rami W., ,"Calvarial
Langerhans cell histiocytosis in an Adult: Typical imaging findings in an atypical age group." Radiology
Case Reports. 14,12. . (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8268

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Radiology Case Reports 14 (2019) 1478–1482

Available online at www.sciencedirect.com

journal homepage: www.elsevier.com/locate/radcr

Case Report

Calvarial Langerhans cell histiocytosis in an Adult:
Typical imaging findings in an atypical age group
Amjad Samara, MDa, Jordan Nepute, MDb, Hsiang-Chih Lu, MD, PhDc,
Richard J. Perrin, MD, PhDc, Rami W. Eldaya, MD, MBAb,∗
a Department

of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA
Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
c Division of Neuropathology, Department of Pathology and Immunology, Washington University School of Medicine,
St. Louis, MO 63110, USA
b Mallinckrodt

a r t i c l e

i n f o

a b s t r a c t

Article history:

Langerhans Cell Histiocytosis (LCH) is a rare disorder characterized by neoplastic prolifera-
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tion of Langerhans-type dendritic cells. LCH is most frequently encountered in the pediatric
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populations, and involvement of the skeletal system is a common manifestation. Herein, we
report a case of LCH presented as an isolated skull lesion in a 66-year-old patient. This presentation has never been reported in the literature at this advanced age and suggests that,
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despite being exceptionally rare, clinicians should consider LCH in the differential diagnosis
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of skull lesions in the elderly with classical radiological appearance.

Skull lesion

© 2019 The Authors. Published by Elsevier Inc. on behalf of University of Washington.

Elderly patient

This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)

Introduction
Langerhans Cell Histiocytosis (LCH) is the most common histiocytic disorder (a group of diseases affecting the macrophages
and dendritic cells). Based on the number of lesions and the
systems involved, LCH could present as a unifocal or localized
pathological process, or a multifocal disease affecting an individual or multiple organ systems. The clinical presentation
is variable and highly dependent on the severity and number
of organs involved and might range from a self-limited condition to a life-threatening fatal disease. Although clinical man-

ifestations and radiological features suggest an LCH diagnosis, histopathologic; and immunohistochemical examination
confirm the final diagnosis.
LCH is most frequently encountered in the pediatric population. The majority of adulthood cases present before the age
of 50 with cases presenting after this age being an exception.
In light of this, we report, to our knowledge, the first case of
LCH presented as isolated skull lesion with classic computed
tomography (CT) and magnetic resonance imaging (MRI) features in a 66-year-old patient with further histopathological
confirmation.

Declaration of Competing Interest: The authors have declared that no competing interests exist.
∗
Corresponding author.
E-mail address: rami.eldaya@wustl.edu (R.W. Eldaya).
https://doi.org/10.1016/j.radcr.2019.09.009
1930-0433/© 2019 The Authors. Published by Elsevier Inc. on behalf of University of Washington. This is an open access article under the
CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Downloaded for Anonymous User (n/a) at Washington University in Saint Louis Bernard Becker Medical Library from ClinicalKey.com by Elsevier on October 21, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.

Radiology Case Reports 14 (2019) 1478–1482

1479

Fig. 1 – MRI at the time of presentation demonstrating the calvarial lesion breaching the inner and outer table to involve the
scalp and dura. (A) Axial T1 shows a left parietal bone T1-isointense lesion; (B,C) Axial T2 (B), and FLAIR (C) images show
that the lesion is heterogeneously hyperintense; (D,E) postcontrast (gadoterate meglumine) axial (D) and parasagittal (E)
demonstrate homogenous enhancement within the lesion that breaches both calvarial tables and involves the dura (white
arrows) and overlying soft tissues.

Case presentation
A 66-year-old male presented to his primary care physician
complaining of recent focal left parietal pain encountered on
palpation. Physical exam revealed an abnormal soft tissue
mass in this region. Brain MRI from 8 years prior was normal.
Given the new findings, a repeat MRI study was obtained.
Brain MRI demonstrated a focal T2 hyperintense enhancing lesion breaching the inner and outer calvarial tables with
extension to and involvement of the underlying dura (Fig. 1).
A subsequently obtained CT demonstrated a lytic lesion with
unequal erosion of the inner and outer tables of the parietal
bone and a sequestered fragment within the lesion (Fig. 2).
Given the appearance and age, the differential diagnosis
included metastasis, plasmacytoma, and lymphoma. While
these findings are very suggestive of LCH, this diagnosis was
never entertained given the patient’s age. All further laboratory work was negative, and surgical excision of the lesion was
performed.
Hematoxylin-and-eosin-stained sections of the lesion
show a piece of skull with a lytic center involved by extensive
fibrosis and a mixed infiltrate, including eosinophils, many
putative benign reactive lymphocytes, and smaller numbers
of larger cells with moderate-to-abundant eosinophilic cyto-

plasm and grooved lobulated nuclei. The larger eosinophilic
cells with grooved nuclei are strongly positive for CD163, S100
protein, and CD1a. BRAF (p.V600E) is negative by immunohistochemistry (Fig. 3). The final diagnosis is LCH.
Given the unusual diagnosis of LCH, the patient was referred to medical oncology. Staging 18-Fluorodeoxyglucose/CT
and postoperative radiographs revealed no residual disease or
distant metastasis (Fig. 4). In addition, BRAF testing was negative. Given gross total resection of the isolated calvarial disease and lack of BRAF mutation, no further treatment was suggested and observation was recommended.

Discussion
LCH is a rare neoplastic disorder of proliferation of
Langerhans-type myeloid dendritic cells that can affect
individual or multiple organs. This rare disease predominantly affects the pediatric population [1]. The disease is even
less common in adults with an annual incidence of 1-2 cases
per million [2]. The International Registry of the Histiocyte
Society case series of 274 adult patients with LCH, the largest
to date, estimates the mean age of onset in adults at diagnosis
is 35 years in females and 33 years in males (with standard
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Fig. 2 – Noncontrast enhanced bone window CT demonstrates a lytic lesion within the left parietal bone; (A) Axial bone
window image shows unequal involvement of the inner and outer calvarial tables with a bony sequestrum; (B) coronal bone
window image shows an associated bony sequestrum within the lesion.

Fig. 3 – Hematoxylin and eosin-stained section (A) and immunohistochemistry for CD163 (B), S100 (C), and CD1a (D)
confirms the diagnosis of LCH.

deviation of 14 and 15 years, respectively), suggesting that
presentation above the age of 50 is an exception [3]. However,
the true incidence of the disease in patients above 50 years
remains unknown.
Solitary organ system involvement of the disease in adults
is estimated to be present in fewer than 50% of patients [3,4].
After lungs, the skeletal system is the second most commonly
involved solitary organ; however, an isolated calvarial lesion

is exceedingly rare and to our knowledge has not been reported in the radiology literature in patients older than 60
years. Chiong et al reported a case of isolated skull LCH in a 41year-old and reviewed the literature, detecting only 4 similar
cases with the oldest being 56-years-old [5].
The pathophysiology of LCH is still unclear with an ongoing debate regarding its etiology. One theory suggests that LCH
is a neoplastic disease based on the observation that a high
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Fig. 4 – Postoperative radiographs and PET/CT demonstrate no residual disease. (A) A radiographic posterior-anterior view
shows postoperative changes without local recurrence; (B,C) PET, Minimum intensity projections (MIP), shows no residual
disease in the calvarium (B, left sagittal MIP projection) or additional sites of disease (C, whole body frontal projection).

percent of LCH lesions are positive for oncogenic BRAF V600E
mutation [6]. Alternatively, other studies argue that LCH is a
disease of immune dysfunction and that LCH lesions develop
secondary to genetic alterations resulting in increased recruitment and activation of immune cells (regulatory T lymphocytes, eosinophils, and plasma cells) [7,8].
Radiological findings of osseous LCH can sometimes mimic
other benign or malignant tumors as well as infections [9].
Our case demonstrated typical CT and MRI imaging findings
of osseous LCH as the CT showed unequal involvement of
the inner and outer tables, consistent with a beveled-edge lesion. Furthermore, the lytic lesion contained a fragment of
intact bone, sometimes referred to as “button sequestrum”
in LCH skull lesions. The MRI also demonstrated heterogeneous but mostly hyperintense T2 and Fluid-attenuated inversion recovery (FLAIR) signal, diffuse enhancement, and extension/involvement of the underlying dura, features that are all
considered typical for LCH skull lesion. Unlike lesions involving other bones, LCH skull lesions are characterized by lack of
periosteal reaction, which was also observed in our case [10].
Additionally, a common central nervous system (CNS) manifestation of LCH is infiltration of the posterior pituitary gland

(radiologically appreciated as loss of the normal posterior pituitary bright spot and thickening of the pituitary stalk), but
this radiological sign was not present in our patient. Despite
the classical imaging findings, the diagnosis remained elusive,
given the exceptional age group and was only achieved with
tissue sampling. Our case suggests that, while exceptionally
rare, LCH can be included in the differential diagnosis of isolated skull lesions in adults if the imaging features are classical.
In adults, the most common differential diagnosies of a
solitary solid lesion breaching the cortex includes lymphoma,
single metastatic lesion, and plasmacytoma; whereas the differential of multiple skull lesions includes multiple metastases, multiple myeloma, leukemia, and lymphoma. Besides
the characteristic radiological appearance of LCH lesions described above, LCH can be distinguished from other differential diagnoses by histologic and immunohistochemical examination. Classically, LCH histologic findings are characterized
as a clonal cellular proliferation of mononuclear cells with
an interspersed inflammatory component, characteristically
eosinophils. By immunohistochemistry, LCH cells are positive
for CD1a, and S100 and negative for CD21 and CD35.
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The choice of treatment for skull LCH depends on the
number of lesions (unifocal vs multifocal disease), and the
involvement of extra-skeletal systems. Watchful observation
or surgical excisions are usually performed for solitary skull
lesions. Other therapeutic options, including local radiotherapy and systemic chemotherapy, could be utilized in
cases of more extensive disease. In our case, the staging
18-Fluorodeoxyglucose/CT and postoperative radiographs revealed no residual disease or distant metastasis. Therefore, no
further systemic treatment was indicated.

Conclusions
Although extremely rare, clinicians should consider LCH in
the differential diagnosis of isolated skull lesions in the elderly with classical radiological appearance. In our patient, CT
and MR imaging showed a solitary beveled-edge lytic lesion of
the left parietal bone with T2/FLAIR signal hyperintensity and
diffuse enhancement. Histology and immunohistochemistry
confirmed LCH diagnosis, and in the absence of other lesions,
surgical excision was a sufficient therapeutic measure.
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